Monocaprin [2277-23-8]
Cat# T9602-1ml
Size : 1mLx10mM(inDMSO)
Marca : TargetMol
Monocaprin
(Synonyms: 2,3-Dihydroxypropyl decanoate) Copy Product InfoMonocaprin is a 1-monoglyceride of capric acid that has antimicrobial activity against enveloped viruses, certain bacteria, and the yeast Candida albicans.
Select Batch
Purity:99.89%
Appearance:Solid
Color:White
COA LCMS HNMR
Product Information
Bioactivity
Chemical Properties
Storage & Solubility Information
| Description | Monocaprin is a 1-monoglyceride of capric acid that has antimicrobial activity against enveloped viruses, certain bacteria, and the yeast Candida albicans. |
| In vitro | C. albicans was the micro-organism that was most sensitive to monocaprin, but S. mutans also showed appreciable sensitivity[1]. |
| Synonyms | 2,3-Dihydroxypropyl decanoate |
| Molecular Weight | 246.34 |
| Formula | C13H26O4 |
| Cas No. | 2277-23-8 |
| Smiles | CCCCCCCCCC(=O)OCC(O)CO |
| Relative Density. | No data available |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year Shipping with blue ice/Shipping at ambient temperature. | |||||||||||||||||||||||||||||||||||
| Solubility Information | DMSO: 55 mg/mL (223.27 mM), Sonication is recommended. ![]() | |||||||||||||||||||||||||||||||||||
| In Vivo Formulation | 10% DMSO+40% PEG300+5% Tween-80+45% Saline: 2.5 mg/mL (10.15 mM), Sonication is recommended. Please add the solvents sequentially, clarifying the solution as much as possible before adding the next one. Dissolve by heating and/or sonication if necessary. Working solution is recommended to be prepared and used immediately. The formulation provided above is for reference purposes only. In vivo formulations may vary and should be modified based on specific experimental conditions. | |||||||||||||||||||||||||||||||||||
Solution Preparation Table | ||||||||||||||||||||||||||||||||||||
DMSO
Note : The dilution table applies only to solid products. For liquid products, please calculate the stock solution based on the stated concentration and/or density. | ||||||||||||||||||||||||||||||||||||




